Condom Market Size & Share Analysis - Growth Trends and Forecast (2027 - 2032)

Market Trends and Insights

Growing awareness about sexually transmitted infections (STIs)

Awareness gives suppliers a recognized prevention rationale, while sustained use determines how fully that recognition can become demand. The HSE commissioned Ipsos B&A to survey 1,134 Republic of Ireland residents aged 18 to 30 online in January 2025, with results weighted to 806,000 adults in that age group. When prompted with multiple possible prevention methods, 89% selected condoms as effective against STI transmission, excluding HIV. Separately, 79% reported having had intercourse without a condom at some point in their lives. For suppliers serving Irish young adults, awareness can support additional unit demand when that recognized prevention rationale leads to condom use on occasions that would otherwise be unprotected.

Sex education initiatives in schools and communities

Education initiatives can strengthen demand by making prevention knowledge teachable before potential users face a purchasing decision. In March 2026, WHO reported that a small but growing number of countries were improving comprehensive sexuality education content and delivery in and outside schools.^[1] In 2025, UNESCO’s O3 Programme supported training for 305 teachers in 23 primary and 13 secondary schools in South Sudan, including hard-to-reach and vulnerable communities. Preparing teachers gives education providers a way to embed prevention knowledge in repeated instruction across participating schools. The opportunity for suppliers is a broader base of informed potential users, with its reach constrained by the uneven educational access identified by WHO.

Rise in government and public health campaigns

Public-health programs can support condom demand through physical provision as well as messages directed at potential users. Brazil’s Ministry of Health completed its 2025 Carnival STI-prevention campaign, promoting condom use alongside other prevention methods and including condom distribution. Separately, UNFPA provided 1.09 billion male condoms worldwide in 2025 through its programs. For manufacturers, these activities establish a commercial route through organized provision, where serving program requirements can matter alongside winning individual retail purchases. The connection between communication and accessible supply is the central opportunity, because a campaign that puts products into users’ hands can address the immediate means of prevention as well as its rationale.

Innovation in latex-free condoms

Latex-free innovation creates demand opportunities through product-specific paths to regulatory access and distribution. On February 28, 2025, the FDA found RB Health (US) LLC’s Durex Polyisoprene Condom substantially equivalent to predicate devices. The decision allowed marketing subject to general controls for contraception and to help reduce pregnancy and STI transmission risks. Separately, Reckitt reported an ongoing global rollout and range extensions for Durex Intensity in H1 2026. For Durex, the US polyisoprene marketing basis and Intensity’s continuing rollout make product-specific authorization and distribution complementary requirements for extending its latex-free offer.

Cultural and religious stigma

Stigma can constrain access through the social exposure attached to both buying condoms and requesting them at a service point. A 2025 qualitative study of young cisgender adults in Poblacion District 4, Burauen, Leyte, Philippines, found that social judgment and gender expectations made women feel ashamed when purchasing condoms. One participant also described embarrassment about asking for condoms at a barangay office because people might talk about them. Moving distribution from a shop to a local office could therefore leave the barrier intact if obtaining supplies still requires a visible request. For services addressing these needs, the remaining constraint is the perceived social cost of being seen seeking protection.

Misconceptions about condom efficacy

Perceived failure risk can constrain demand even when users understand what condoms are intended to do. Interviews conducted from November 2023 to March 2024 with adolescent girls and young women in a South African school-based HIV prevention program captured fear that condoms could burst and were unsafe. Researchers described that fear as partly a misconception and as a reason participants chose to use pre-exposure prophylaxis (PrEP). For condom suppliers, the barrier is confidence in protection at the moment of use, which additional awareness alone would not necessarily resolve. Rebuilding trust therefore adds a communication burden before this audience can be expected to choose the product confidently.

*Our forecasts treat driver/restraint impacts as directional, not additive. The impact forecasts reflect baseline growth, mix effects, and variable interactions.

Condom Market Segment Analysis

Latex accounted for a 79.57% share of the condom market size in 2026, making it the largest segment. Tianjin Human-Care Latex Co., Ltd., a wholly owned subsidiary of Lifestyles Health Industry Co., Ltd., operates 5 natural-latex condom production lines in Tianjin, China. Cupid Limited reported for FY2025-26 that its natural-rubber-latex female condom held WHO/UNFPA prequalification and was supplied to more than 50 countries. For suppliers, specialized production infrastructure and qualified products with international reach give latex a commercial foundation across different condom formats and routes to buyers.

Non-latex is forecast to be the fastest-growing segment, at a CAGR of 10.14% from 2027 to 2032. Reckitt reported that its nitrile male condom Durex Intensity became one of its best-selling portfolio products after launching in Europe in early 2025. The company linked nitrile to body-heat transfer and enhanced sensation without compromising protection. That product result connects a material choice with the experience offered to buyers, giving suppliers a specific basis for differentiation.

Men represented an 88.84% condom market share in 2026 and formed the largest end-user segment. For its November 1, 2025, to October 31, 2030, state contract, South Africa’s National Treasury estimated annual requirements of 800 million male condoms and 200 million male youth condoms. The separate youth category creates another defined buyer requirement within the male-condom business. Estimated annual requirements give suppliers a scale for planning production, while the categories define the offers public buyers seek. This gives manufacturers a product-specific route into institutional supply alongside consumer-facing brand competition.

Women are forecast to be the fastest-growing segment, at a CAGR of 9.55% from 2027 to 2032. On July 1, 2025, UNFPA recorded an award covering female condoms alongside male latex condoms and personal lubricants for multiple countries and territories. In May 2026, UNDP invited bids for multiple non-exclusive global long-term agreements covering WHO/UNFPA-prequalified female condoms, male condoms and lubricants, with submissions due June 8, 2026. That requirement makes prequalification commercially significant for manufacturers seeking institutional female-condom business. The opening is qualified participation in multi-product prevention procurement, giving suppliers a buyer route beyond establishing a standalone consumer brand.

Pharmacies and drug stores held the largest segment share, at 44.8% in 2026. Haringey’s 2025 pharmaceutical needs assessment recorded 23 pharmacies in the English borough registered to provide free condoms through Come Correct for young people under 25. The local network gives the pharmacy channel a defined service setting in which access is organized around an eligible group. For suppliers addressing that setting, participating outlets provide an identifiable route for reaching the program’s intended users. Pharmacy participation can consequently serve a prevention program as well as individual product purchases.

Online retail stores are forecast to be the fastest-growing segment, at a CAGR of 10.4% from 2027 to 2032. In 2025, Reckitt said Durex livestreaming and social commerce in China drove higher full-price sell-through and more efficient recruitment. Condom brands can therefore treat livestream selling as an acquisition tool that does not depend on discounting.

Geography Analysis

North America Condom Market

North America held a 34.85% condom market share in 2026, making it the largest regional market. On February 3, 2026, New York City’s Department of Citywide Administrative Services awarded Global Protection Corp. a 5-year requirements contract valued at USD 6.11 million for condoms and lubricant packets for the city’s Condom Availability Program. An April 2026 NYC Health announcement confirmed the renewed 5-year partnership with ONE Condoms, the brand owned by Global Protection Corp., with supply through January 2031. By packaging condoms with lubricant, the procurement creates a supplier opportunity around a complete prevention offer, making the ability to serve the combined requirement part of the commercial case.

Asia-Pacific Condom Market

Asia-Pacific is forecast to be the fastest-growing region, at a CAGR of 10.42% from 2027 to 2032. Thailand’s Thai Nippon Rubber Industry Public Company Limited implemented one concentrated-natural-latex condom production machine in the second quarter of 2026. Its project plan aimed to improve revenue-generating capability and gross profit margin through advanced production technology. For Thai Nippon, the commercial test is whether the implemented natural-latex technology supports both revenue generation and gross margin, rather than equipment installation alone.

In Europe, England’s provisional 2025 official statistics in development showed reported condom use at last sex with a partner of another sex in 19.8% of women’s and 16.4% of men’s face-to-face sexual-health-service attendances. This English country case concerns use within a clinical service setting, where product provision can be paired with prevention communication. Brazil’s Unified Health System offers a South American example, providing external and internal condoms, including textured and sensitive varieties, through primary care and specialized STI services on individual demand without registration or quantity limits. South Africa’s national example within Middle East and Africa is a state contract covering male and female condoms and lubricant. For suppliers, these examples suggest service-linked communication in England, public-health distribution in Brazil and combined condom-and-lubricant offers for South Africa’s state buyer.

Regulatory Framework and Outlook

Selected jurisdictions are compared from the perspective of a condom manufacturer seeking commercial market entry. Product material and device class shape the documentation and technical work required for an offer. Natural-rubber-latex male condoms have specific technical or labeling requirements in the United States and Argentina, while China’s scheduled unique device identification requirement applies to Class II devices manufactured from June 1, 2027. These distinctions make the choice of product and entry route commercially significant alongside the selection of a destination country.

US Class II controls and Saudi Arabia’s authorization and premarketing quality-inspection requirements justify medium ratings, with continuity supported by the completed US quality transition and maintained Saudi oversight framework. Germany’s medium rating reflects conformity and language duties, while the December 2025 proposal for narrower non-implantable Class IIb documentation assessment, pending in October 2026 with additional review for concerns, supports easing subject to adoption. China’s medium rating weighs registration work against the conditional multipack exception, with hardening for remaining Class II products manufactured from June 1, 2027, when the scheduled UDI requirement applies. Argentina’s medium rating retains latex-male-condom technical duties, while the March 19, 2026, notification procedure supports easing for eligible Class I/II imports with required documentation and continuing national technical compliance.

Value Chain Stages

The value chain compares contract manufacturing, branded commercialization and downstream distribution as different sources of supplier earnings. In FY2025, commercial-market sales were Karex’s largest revenue contributor across its business, covering original equipment and original design manufacturing for brands and private labels. Its subsidiaries’ manufacturing roles, proprietary brands and US distribution subsidiary show how successive activities can sit within one group. Vertical integration can therefore expose a supplier to more sales interfaces, while each activity requires its own operating capability.

In FY2025, Karex’s US subsidiary Global Protection Corp. completed a facility relocation that temporarily disrupted order fulfillment.^[2] Its warehousing and distribution capacity reached 3 times the previous level. For integrated suppliers, the commercial benefit of a larger distribution footprint depends on managing the transfer of operations while preserving the order fulfillment that customers rely on.

Key Opportunities for Market Participants

Institutional purchasing offers different openings for eligible local manufacturers and suppliers preparing for separately planned male- and female-condom procurements. On October 1, 2026, India’s Central Medical Services Society invited Class I and Class II local-supplier manufacturers to bid for 2 NACO condom schedules totaling a tentative 115.5 million pieces.^[3] Bids are due October 29, 2026, with 1-year rate contracts beginning on award. South Africa’s Health procurement plan separately scheduled male- and female-condom processes to begin November 12 and 13, 2026.

The Indian invitation gives qualifying manufacturers a defined submission window, making eligibility the first commercial screening decision. South Africa’s separate planned processes justify product-specific preparation, while their planning status makes an order commitment premature. The strongest near-term opening is converting manufacturing capability into an eligible institutional offer, with preparation scaled to how far each purchasing process has progressed.